NCT05512481
- Conditions
- Acral Melanoma, Apatinib, Camrelizumab, +15 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Temozolomide
Explore clinical trials studying Temozolomide. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Temozolomide trial results
NCT03079440
- Conditions
- Adenocarcinoma, Capecitabine, Carcinoma, +10 more
- Locations
-
- Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea